SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM) today announced their partnership
with Emmy® Award-winning actress Annie
Murphy to launch "House Rules," a national campaign to
generate awareness of Evofem's hormone-free contraceptive, Phexxi,
while also highlighting the contraceptive journey of millions of
women, like Annie, who are tired of dealing with the side effects
of hormones in their birth control.
Annie Murphy stars in a 60-second
TV commercial where she talks about her personal birth control
journey and all the reasons why Phexxi is the right contraceptive
for her. She also empowers women to choose what they want and
that they should live by their "rules," especially when it comes to
choosing a birth control method.
"After trying multiple hormonal birth control methods for ten
years and finding that none were right for me, I thought something
was wrong with me," said Annie
Murphy. "Like millions of other women, I decided to avoid
hormonal contraception because of the side effects that I
experienced, which included depression, mood swings, and
irritability. After cycling through multiple options, I was not
using any form of contraception. With Phexxi I found an option that
works for me and fits my needs completely – which meant no messing
with my hormones and no daily pills. With "House Rules" I am proud
to empower women to learn about Phexxi and to demand more from
their contraception."
Phexxi is the first and only FDA-approved hormone-free,
use-it-only-when-you-need-it prescription vaginal gel that puts
women in control of their bodies, their sex life, and their birth
control needs.
"We are thrilled and honored to partner with Annie Murphy because she is the perfect
embodiment of the Phexxi woman: strong, bold, and confident. Her
birth control journey unfortunately is not uncommon and together we
are excited to help bring greater awareness to Phexxi,
hormone-free, on-demand birth control that women only use when they
need it and never when they don't," said Saundra Pelletier, CEO of Evofem Biosciences.
"We are amplifying Phexxi through Annie's "House Rules" because we
know that some women may experience side effects from synthetic
hormones and we firmly believe that women should call the shots
when it comes to their bodies, their decisions, their quality of
life, and most certainly their birth control."
Watch the "House Rules" commercial and Annie's birth control
story on demand on YouTube. Join the conversation on social media,
including Instagram (@Phexxi and @EvofemBiosciences),
Facebook (@Phexxi and @Evofem), and Twitter
(@Evofem).
About Phexxi
Phexxi is an on-demand method of birth control used to prevent
pregnancy. Phexxi is not effective when used after sex. For
more information about Phexxi, talk to your healthcare provide and
see full Product Information at www.phexxi.com.
Important Safety Information
- Rare cases (0.36%) of bladder and kidney infections have been
reported. If you have a history of urinary tract problems that keep
coming back, you should not use Phexxi.
- Contact your healthcare provider if you are experiencing
genitourinary side effects such as vaginal burning, itching,
discharge, genital discomfort (including in male partners), yeast
infection, urinary tract infection or bacterial vaginosis.
- Phexxi does not protect against sexually transmitted
infections, including HIV.
Please report side effects by contacting Evofem Biosciences
toll-free at 1-833-EVFMBIO or contact FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
Intended for United States
residents only.
About Evofem Biosciences
Evofem Biosciences, Inc.,
(NASDAQ: EVFM) is developing and commercializing
innovative products and product candidates to address unmet
needs in women's sexual and reproductive health, including
hormone-free, woman-controlled contraception and protection from
certain sexually transmitted infections (STIs). For more
information, please visit evofem.com.
Phexxi® and the Phexxi logo are registered trademarks of Evofem
Biosciences, Inc. Trademarks, registered or otherwise, are the
property of their respective owner(s).
© 2021 Evofem Biosciences, Inc.
Forward-Looking Statements
This press release includes "forward-looking statements," within
the meaning of the safe harbor for forward-looking statements
provided by Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995.
Various factors could cause actual results to differ materially
from those discussed or implied in the forward-looking statements,
and you are cautioned not to place undue reliance on these
forward-looking statements, which are current only as of the date
of this press release. Each of these forward- looking statements
involves risks and uncertainties. Important factors that could
cause actual results to differ materially from those discussed or
implied in the forward-looking statements, or that could impair the
value of Evofem Biosciences' assets and business, are disclosed in
the Company's SEC filings, including its Annual Report on Form 10-K
for the year ended December 31, 2020 filed with the SEC
on March 4, 2021. All forward-looking statements are expressly
qualified in their entirety by such factors. The Company does not
undertake any duty to update any forward-looking statement except
as required by law.
Media
Contact
|
Investor Relations
Contact
|
Alyssa Bleiberg
|
Amy
Raskopf
|
Real Chemistry
|
Evofem Biosciences,
Inc.
|
ableiberg@realchemistry.com
|
araskopf@evofem.com
|
Mobile: (973)
432-7289
|
Mobile: (917)
673-5775
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/emmy-award-winner-annie-murphy-partners-with-evofem-biosciences-to-talk-sex-contraception-and-why-she-chose-phexxi-301372087.html
SOURCE Evofem Biosciences, Inc.